Advertising Disclosure

Researchers uncover how key Alzheimer’s proteins work together to speed up the disease

A new review shows amyloid-β and tau act in a synergistic cycle that drives cognitive decline

Updated:

Avatar photo
By:
Avatar photo

Mark Huffman
Reporter

Mark Huffman has covered consumer issues since 2004, with a special focus on protecting and empowering older adults. A former news correspondent for the Associated Press Radio Network, Westwood One, and ConsumerAffairs, Mark brings decades of journalistic experience to RetirementLiving.com. He is passionate about giving consumers a voice and helping them make informed decisions. Mark has also created educational content, including Senior Scam Alert, a video resource designed to help seniors recognize and avoid fraud. He holds a B.A. from the University of Kentucky and lives with his family in Richmond, Virginia.
shawn-day-unsplash

Photo by Shawn Day on Unsplash

Key Insights

  • Researchers at Temple University’s Alzheimer’s Center have published a sweeping new review on how amyloid-β and tau—the two defining proteins of Alzheimer’s disease—interact to accelerate dementia.
  • Led by neuroscientist Domenico Praticò, MD, the paper synthesizes recent evidence showing these proteins act together, not separately, to drive synaptic failure, neurodegeneration, and cognitive decline.
  • The findings point toward new therapeutic strategies that target the disease earlier by addressing the shared biology of plaques and tangles.

A new review from researchers at the Alzheimer’s Center at Temple University is reframing how scientists understand the biological drivers of Alzheimer’s disease. Rather than acting independently, the two hallmark proteins of the condition—amyloid-β and tau—appear to interact in ways that intensify brain damage and speed disease progression.

The paper, led by Dr. Domenico Praticò, professor of Neurosciences at the Lewis Katz School of Medicine at Temple University, brings together the latest research on how amyloid plaques and tau tangles reinforce one another. These abnormal protein accumulations are responsible for the memory loss and cognitive impairment that define Alzheimer’s disease.

“For many years, amyloid-β and tau were studied as largely separate processes,” Dr. Praticò said. “What’s becoming clear is that they engage in a complex and synergistic relationship that accelerates disease onset and progression.”

Brain cell communication disruption

Alzheimer’s disease is marked by early disruptions in communication between brain cells, known as synaptic dysfunction. According to the review, these changes occur well before large-scale neuron loss becomes evident. As the disease advances, however, this early dysfunction evolves into widespread neurodegeneration and irreversible neuronal death.

The authors highlight growing evidence that amyloid-β can trigger or worsen tau pathology—and that tau, in turn, can amplify amyloid-driven damage. This back-and-forth interaction appears to magnify injury within particularly vulnerable brain circuits.

“The molecular mechanisms through which amyloid-β can promote tau pathology, and vice versa, amplify damage,” Dr. Praticò explained, underscoring why treatments aimed at only one protein have had limited success.

What the research shows

By critically evaluating recent experimental and clinical findings, the review offers a unified framework for understanding how amyloid-β and tau intersect at different stages of Alzheimer’s disease. This integrated perspective, the researchers argue, could help guide the development of therapies designed to slow or even prevent disease progression.

“Our goal was to offer a clearer roadmap for future research,” Dr. Praticò said. “If we better understand how these two proteins interact, we may be able to design treatments that target Alzheimer’s earlier and with greater precision.”

As Alzheimer’s continues to affect millions worldwide, the Temple University review adds to a growing body of evidence suggesting that tackling the disease will require strategies that address its interconnected biology — not just its individual parts.